EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-10-24
Management highlights
- Welcome of Interim CFO Laura Russell, who brings over 20 years of semiconductor experience.
- Mixed Q3 results: Earnings exceeded guidance but revenues fell below estimate. Gross margin of 35.2% was higher than expected, driven by lower operating expenses. Revenues down due to softer EV/HEV and portable electronics.
- Ongoing challenges in General Industrial and EV/HEV markets; global manufacturing contraction weighs on Industrial, and EV/HEV growth is behind last year's pace.
- Ribbon-cutting of new curamik power substrate factory in China, which will manufacture AMB substrates and support regional capacity strategy.
- Opportunities in industrial segments like medical devices, data centers, battery energy storage systems; EV/HEV with new design wins and capacity investments in China.
Segment performance
For AES, revenue decreased 3% versus the prior quarter to $112 million, with curamik sales down more than 35% due to customer inventory correction and lack of demand recovery. For EMS, revenue decreased less than 1% to approximately $94 million, primarily due to lower EV/HEV sales, partially offset by seasonally higher portable electronic sales and improved industrial sales. AES contributed around 53.3% of total revenues ($112M out of $210M), while EMS contributed around 44.8% ($94M out of $210M).
Guidance
- Q4 net sales expected to range between $185 million and $200 million, midpoint down ~8% from Q3.
- Gross margin projected to be in the range of 31.5% to 33% for Q4.
- Adjusted EPS expected to range from a loss of $0.15 to $0.15 of earnings.
- Full year tax rate projected to be approximately 27%.
Risks
- Ongoing contraction in global manufacturing activity impacting the Industrial segment.
- Soft order patterns and lack of demand recovery in the EV/HEV segment.
- Competitive dynamics in the ADAS market.
- Macro challenges such as monetary policy and election uncertainty affecting industrial demand.
Q&A highlights
Q: Daniel Moore asks about the sequential decline in revenue implied in the Q4 guide.
A: Colin Gouveia states the main reasons are the wireless program ending in Q3, seasonal decline in portable electronics, curamik not recovering, and customer de-stocking for year-end.
Q: Craig Ellis inquires about the industrial business and power substrate ramp.
A: Colin Gouveia discusses industrial opportunities in medical, data centers, BESS, etc., and Laura Russell talks about OpEx related to the substrate factory ramp.
Q: Daniel Moore asks about margins and EMS.
A: Laura Russell and Colin Gouveia discuss margin management, utilization issues, and margin expansion efforts.
Q: Craig Ellis asks about M&A and cash return to shareholders.
A: Colin Gouveia talks about M&A strategy and Laura Russell discusses opportunistic share buybacks based on capital allocation priorities.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.98 | $0.85 | +15.3% | $1.24 |
| Revenue | $210.3M | $191.8M | +9.7% | $229.1M |
Transcript
October 24, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.